|
Volumn 89, Issue 9, 2010, Pages 1210-1213
|
Evaluation of the introduction of a new treatment for the termination of pregnancy in the Netherlands
|
Author keywords
Absence of guidelines; Medical termination of pregnancy; Mifepristone; Misoprostol
|
Indexed keywords
MIFEPRISTONE;
MISOPROSTOL;
ABORTIVE AGENT;
ARTICLE;
GYNECOLOGY;
HUMAN;
MEDICAL PRACTICE;
NETHERLANDS;
OFF LABEL DRUG USE;
PREGNANCY TERMINATION;
PRIORITY JOURNAL;
QUESTIONNAIRE;
SINGLE DRUG DOSE;
TEACHING HOSPITAL;
ABORTION, MISSED;
CLINICAL PRACTICE;
CURETTAGE;
DOSE RESPONSE;
DRUG COMBINATION;
FEMALE;
INDUCED ABORTION;
OBSTETRICS;
PREGNANCY;
PREMEDICATION;
PROCEDURES;
STATISTICS AND NUMERICAL DATA;
CLINICAL PROTOCOL;
COMBINATION CHEMOTHERAPY;
EVALUATION STUDY;
FIRST TRIMESTER PREGNANCY;
GYNECOLOGIST;
MISSED ABORTION;
MONOTHERAPY;
NORMAL HUMAN;
PRACTICE GUIDELINE;
SECOND TRIMESTER PREGNANCY;
ABORTIFACIENT AGENTS;
ABORTION, INDUCED;
ABORTION, MISSED;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
FEMALE;
GYNECOLOGY;
HUMANS;
MIFEPRISTONE;
MISOPROSTOL;
NETHERLANDS;
OBSTETRICS;
OFF-LABEL USE;
PHYSICIAN'S PRACTICE PATTERNS;
PREGNANCY;
PREGNANCY TRIMESTERS;
PREMEDICATION;
QUESTIONNAIRES;
VACUUM CURETTAGE;
|
EID: 77956308808
PISSN: 00016349
EISSN: 16000412
Source Type: Journal
DOI: 10.3109/00016349.2010.501856 Document Type: Article |
Times cited : (5)
|
References (5)
|